Mark E. Mlotek
Executive Vice President,
pharmaceutical science
Henry Schein
Netherlands
Biography
Mr. Mlotek, now in his 21st year with Henry Schein, Inc., currently serves as Executive Vice President and Chief Strategic Officer, a position he has held since 2012. He is a member of the Company's Executive Management Committee and a member of the Company's Board of Directors. In his current role, Mr. Mlotek has three main priorities: worldwide merger and acquisition activity for the Company; business development, including important supplier partnership arrangements; and worldwide strategic planning.
Research Interest
Pharmacogenomics & Pharmacoproteomics
